Synovial fibroblasts modulate endothelial activation in an acute injury-on-a-chip model
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2524677123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Hannah M Zlotnick und 11 weiteren Autor:innen. Beteiligte Einrichtung: BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303. Hauptthemen laut MEDLINE: Synovial Membrane, Fibroblasts, Endothelial Cells, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCRR NIH HHS, NIAMS NIH HHS, HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
Most patients who sustain an acute joint injury develop degenerative joint disease or osteoarthritis (OA). Animal models have informed the design of OA therapeutics; however, no disease-modifying therapy has successfully translated to human patients. Thus, there is a strong motivation to develop humanized in vitro platforms to fill a critical gap in knowledge of disease progression postinjury. Here, we develop an acute injury-on-a-chip model of the synovium, a vascularized, joint-lining tissue that has been implicated in OA progression and as a key driver of joint disease. We apply this chip-based system to investigate the crosstalk between endothelial cells, lining an engineered vessel, and synovial fibroblasts, embedded within an extracellular matrix hydrogel. Our data indicate that synovial fibroblasts, rather than initiating disease, attempt to support and maintain vascular function in the presence of acute inflammation (i.e., interleukin-1β). Such knowledge may provide new targets for OA therapeutics, preventing the progression from joint injury to disease in patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BioFrontiers Institute, University of Colorado Boulder, Boulder, CO 80303.
- Department of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, CO 80303.
- Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104.
- Department of Biomedical Engineering, University of Colorado Boulder, Boulder, CO 80303.
- Cartilage Regeneration using Advanced Technologies to Enable Motion Center, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA 19104.
- Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.
ORCID-Profile: Hannah M Zlotnick, Jonathan T Makhoul, Hannah K Weppner, Carla R Scanzello, Laurel E Hind, Jason A Burdick
Förderung
- NCRR NIH HHS
- NIAMS NIH HHS
- HHS | National Institutes of Health (NIH)
- CU Boulder Uplift Program
- CU Boulder CHER4U Program
- Schmidt Family Foundation (SFF)
- National Science Foundation (NSF)
Zitieren
APA
Zlotnick, H. M., Goddard, D. N., Calo, C. J., Dhand, A. P., Davidson, M. D., Solsona-Pujol, A., Makhoul, J. T., Weppner, H. K., Wong, M., Scanzello, C. R., Hind, L. E., & Burdick, J. A. (2026). Synovial fibroblasts modulate endothelial activation in an acute injury-on-a-chip model. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2524677123
Vancouver
Zlotnick HM, Goddard DN, Calo CJ, Dhand AP, Davidson MD, Solsona-Pujol A, et al. Synovial fibroblasts modulate endothelial activation in an acute injury-on-a-chip model. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2524677123
BibTeX
@article{Zlotnick2026,
author = {Zlotnick, Hannah M and Goddard, Declan N and Calo, Christopher J and Dhand, Abhishek P and Davidson, Matthew D and Solsona-Pujol, Aina and Makhoul, Jonathan T and Weppner, Hannah K and Wong, Melissa and Scanzello, Carla R and Hind, Laurel E and Burdick, Jason A},
title = {Synovial fibroblasts modulate endothelial activation in an acute injury-on-a-chip model},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2524677123}
}
EUVIMED